Raed Dweik, MD

Surgeon:

No

Treats:

Adults Only

Raed A. Dweik, M.D. is the Director of the Pulmonary Vascular Program in the Department of Pulmonary and Critical Care Medicine in the Respiratory Institute at Cleveland Clinic.  He is board certified in internal medicine, pulmonary disease, and critical care medicine.  Dr. Dweik's clinical interests are in pulmonary hypertension, asthma, critical care, and chronic beryllium disease. He has a joint appointment in the department of Pathobiology in the Lerner Research Institute (LRI) and is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. 

 Dr. Dweik's research interests are in exhaled breath analysis and the role of nitric oxide in cardiopulmonary physiology and disease especially pulmonary hypertension and asthma.  He served on several related national and international panels and committees including: the American Thoracic Society (ATS) Chronic Beryllium Disease Diagnosis and Management Committee, the ATS taskforce to Standardize measurement of Nitric Oxide (NO) in exhaled breath, and the Joint ATS-ERS taskforce on Exhaled Breath Condensate (EBC).  He also chaired the ATS committee writing the guidelines for the use and interpretation of exhaled NO (FENO) in clinical practice and the ATS committee on pulmonary hypertension phenotypes.  

 Dr. Dweik has been the recipient of many awards including The Best Doctors in America, America's Top Physicians, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, Who's Who in America, and Who's Who in the World. Dr. Dweik has been the recipient of the Distinguished Teacher Award from the Internal Medicine Residency Program in 2000-01, 2003-04, 2004-05, 2006-07, 2007-08 and the Pulmonary Fellowship Program in 2006-07.  In 2007, he also received the Scholarship in Teaching Award from Case Western Reserve University.

Dr. Dweik is an editorial board member of the Journal of Clinical and Translational Science, the Open Nitric Oxide Journal, and the Journal of Breath Research of which he is a Founding Member.  He is also a journal reviewer for several peer-reviewed publications including: The Lancet, American Journal of Respiratory and Critical Care Medicine, Chest, Thorax, American Journal of Physiology, Lung Cell Molecular Physiology, European Respiratory Journal, Cleveland Clinic Journal of Medicine, The Journal of Respiratory Diseases, Annals of Allergy, Asthma & Immunology. He is a Fellow of the American College of Physicians (FACP), the Royal College of Physicians of Canada (FRCPC), the American College of Chest Physicians (FCCP), the Society of Critical Care Medicine (FCCM), the American Heart Association (FAHA), and the Pulmonary Vascular Research Institute (PVRI).  He is a member of the American Thoracic society (ATS) and a founding member of the International Association for Breath Research (IABR).

After receiving his medical degree from the University of Jordan Faculty of Medicine, Dr. Dweik completed his internship and residency in internal medicine at Miami Valley Hospital and Wright State University in Dayton, OH. He completed his fellowship in pulmonary and critical care medicine at The Cleveland Clinic.

Fellowship - Cleveland Clinic

Pulmonary Disease/Critical Car
Cleveland, OH USA
1996

Residency - Wright State University

Internal Medicine
Dayton, OH USA
1993

Internship - Miami Valley Hospital

Internal Medicine
Dayton, OH USA
1990

Internship - Jordan University Hospital

Rotating
Amman Jordan
1989

Medical School - University of Jordan Faculty of Medicine

Amman Jordan
1988

• Internal Medicine- Pulmonary Disease
• Internal Medicine- Critical Care Medicine
• Internal Medicine

Acute respiratory distress syndrome(ARDS), asthma, beryllium disease, chronic beryllium disease, pneumonia, pulmonary embolism, pulmonary hypertension, scleroderma, sepsis

• Listed in "Best Doctors in America": 2005- Present
• Distinguished Teacher Award Internal Medicine Residency Program: 2000-01, 2003-04, 2004-05, 2006-07, 2007-08. 
• Teacher of the Year Award Pulmonary Fellowship Program: 2006-2007
• Cleveland Clinic Foundation Innovator Award 2004
• Listed in "Guide to America's Top Physicians": Edition 2003
• Listed in Marquis "Who's Who":
  • In the World: 18th Edition, 2001- to present
  • In America: 55th Edition, 2001- to present
  • In Science and Engineering: 5th Edition, 2000- to present
  • In Medicine and Healthcare: 3rd Edition, 2000- to present

• American College of Physicians, Fellow (FACP)
• American College of Chest Physicians, Fellow (FCCP)
• Royal College of Physicians of Canada, Fellow (FRCPC)
• American Heart Association (AHA), Fellow (FAHA)
• Society of Critical Care Medicine (SCCM), Fellow (FCCM)
• Pulmonary Vascular Research Institute (PVRI), Fellow
• American Thoracic Society (ATS), Member
• American Association for the Advancement of Science, Member
• American Physiological Society, Member
• International Association for Breath Research, Founding Member

• Bronchoscopy
• Exhaled Breath Analysis
• Pulmonary Function Testing
• Treating Asthma With Bronchodilators

• Acute Respiratory Distress Syndrome(ARDS)
• Asthma
• Beryllium Disease
• Chronic beryllium disease
• Pneumonia
• Pulmonary Embolism
• Pulmonary Hypertension
• Scleroderma
• Sepsis

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/2/2013, Dr. Dweik has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

• Arabic
• English